Population-based study of acute- and long-term care costs after stroke in patients with AF.

ABSTRACT:

Background

New treatments for atrial fibrillation patients have been shown to be effective at reducing subsequent vascular event recurrence. However, there are few data on stroke costs in atrial fibrillation patients to allow the cost-effectiveness of these treatments to be assessed.

Aims

Using data from a population-based study, we assessed the acute and long-term costs of stroke in atrial fibrillation patients.

Methods

Health-care costs one-year before and five-years after stroke were obtained from a large population-based study (Oxford Vascular study). Costs were assessed for the three-months poststroke (acute period) and annually thereafter (postacute period). Annual postacute costs were compared with annual baseline costs. Based on patients' living arrangements,

SUBMITTER: Luengo-Fernandez R 

PROVIDER: S-EPMC6016735 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature